Company: PFSA
Filing Date: 2025-04-28
Form Type: S-4/A
Source: 0001213900-25-035718
Chunk: 39

Company: Profusa, Inc.
Filing Date: 2025-04-28
Form: S-4/A
Chunk 39
---
,897,500shares issuable pursuant to outstanding NorthView Rights. (5)Represents $1,575,000 of transaction costs being paid in shares of New Profusa Common Stock at $10 per share. (6)Assumes 1,000,000shares issuable upon conversion of the $10million first tranche of the PIPE Investor convertible note facility ($22.22million total) at $10 per share. (7)Senior secured convertible note which includes 710,220 Sponsor shares that were utilized as inducement shares for the notes. (8)Represents 1,385,901shares issued upon the conversion and exchange of Profusa bridge notes and 2,899,111shares issued in exchange for the shares issued pursuant to the Bridge Note Buyout Agreement. (9)Represents shares from the conversion of the NorthView working capital convertible loan at a $2.22 per share. As noted above, there are currently outstanding an aggregate of 17,404,250 warrants to acquire shares of NorthView Common Stock, which is comprised of 7,347,500 private placement warrants held by the Sponsor and Representatives, 9,487,500 public warrants, and 569,250 Representative Warrants. Each of our outstanding whole warrants is exercisable for one share of New Profusa Common Stock commencing 30 days following the Closing and terminating five years from the Closing and will entitle the holder thereof to purchase one share of New Profusa Common Stock in accordance with its terms. Therefore, as of the date of this proxy statement/prospectus, if we assume that each outstanding whole warrant is exercised and one share of New Profusa Common Stock is issued as a result of such exercise, with payment to New Profusa of the exercise price of $11.50 per warrant for one whole share, our fully diluted share capital would increase by a total of 17,404,250shares, with approximately $200.1 million paid to exercise the warrants. The Private Placement Warrants (including the common stock issuable upon exercise of the Private Placement Warrants) are (with limited exceptions) not transferable, assignable or salable until 30 days after the completion of an initial business combination and they are not redeemable by NorthView so long as they are held by the original holders or its permitted transferees. Otherwise, the Private Placement Warrants have terms and provisions that are identical to those of the NorthView Public Warrants. If the Private Placement Warrants are held by holders